Long-term ADT Use Can Diminish Tumors’ Visibility on Scans, Study Reports

Long-term ADT Use Can Diminish Tumors’ Visibility on Scans, Study Reports
Long-term use of androgen deprivation therapy (ADT) can make prostate cancer lesions difficult or impossible to see on some imaging scans, even in tumors that continue to grow, a new study shows. Its scientists recommended that patients with aggressive cancer undergo scans before starting with ADT. The study, “Impact of long-term androgen deprivation therapy on PSMA ligand PET/CT in patients with castration-sensitive prostate cancer," was published in the European Journal of Nuclear Medicine and Molecular Imaging. Imaging of recurrent prostate canc
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *